Author:
Buckner Jan C.,Forouzesh Bahram,Erlichman Charles,Hidalgo Manuel,Boni Joseph P.,Dukart Gary,Berkenblit Anna,Rowinsky Eric K.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference34 articles.
1. Schmelzle T, Hall MN (2000) TOR, a central controller of cell growth. Cell 103:253–262. doi: 10.1016/S0092-8674(00)00117-3
2. Bjornsti MA, Houghton PJ (2004) The TOR pathway: a target for cancer therapy. Nat Rev Cancer 4:335–348. doi: 10.1038/nrc1362
3. Del Bufalo D, Ciuffreda L, Trisciuoglio D et al (2006) Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus. Cancer Res 66:5549–5554. doi: 10.1158/0008-5472.CAN-05-2825
4. Pantuck AJ, Zeng G, Belldegrun AS, Figlin RA (2003) Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: exploiting the hypoxia-induced pathway. Clin Cancer Res 9:4641–4652
5. Skotnicki JS, Leone CL, Smith AL (2001) Design, synthesis, and biological evaluation of C-42 hydroxyesters of rapamycin: the identification of CCI-779. Clin Cancer Res 7:3749S–3750S
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献